| 
             
			
			 Medicare, the U.S. health insurance program for the elderly that 
			also covers Americans with kidney failure, will not pay for dialysis 
			and hospice at the same time. This forces terminally ill patients to 
			choose between continuing on dialysis or accessing hospice care, 
			which may provide more comfort and support at the end of life, 
			researchers note in JAMA Internal Medicine. 
			 
			For the current study, researchers examined data on more than 
			770,000 dialysis patients covered by Medicare who died between 2000 
			and 2014. Overall, just one in five were receiving hospice services 
			when they died. 
			 
			Among patients who did receive hospice care, 42 percent were 
			enrolled for three or fewer days. Compared with dialysis patients 
			who didn't receive hospice care, those enrolled in hospice for three 
			or fewer days were more likely to have been hospitalized or admitted 
			to intensive care units (ICU) in the last month of life. But they 
			were less likely to die in the hospital or undergo invasive 
			procedures. 
			
			  
			"We found that people on dialysis who did enroll in hospice spent 
			much less time in hospice than patients with other serious illnesses 
			like cancer and heart disease, and those who did spend more time on 
			hospice had lower healthcare costs," said lead study author Dr. 
			Melissa Wachterman, a researcher at Harvard Medical School and 
			Brigham and Women's Hospital in Boston. 
			 
			Hospice is a benefit typically available to people with a life 
			expectancy of six months or less. People in hospice generally stop 
			active treatment and instead receive care focused on comfort as well 
			as emotional support for patients and their loved ones. 
			 
			Terminal kidney failure patients can have intense pain and worse 
			quality of life than people with cancer or dementia at the end of 
			life, Wachterman said by email. 
			 
			"Patients with kidney failure stand to benefit greatly from the care 
			hospice has to offer and yet they are about half as likely to 
			receive hospice as those with other serious illnesses like cancer 
			and heart disease," Wachterman said. 
			 
			One goal of hospice is also to avoid costly and often unnecessary 
			interventions that don't improve quality of life or extend longevity 
			for people with terminal illnesses. 
			
			  
			
            [to top of second column]  | 
            
             
  
            
			In the current study, average Medicare costs over the last week of 
			life were similar for dialysis patients who didn't go to hospice and 
			those who enrolled only for three or fewer days before they died. 
			Without hospice, the tab came to $10,871 compared with $10,756 with 
			a brief hospice stay. 
			But when patients spent more than 15 days in hospice before they 
			died, average Medicare costs over the final week of life were 
			$3,221. 
			 
			Just 35 percent of these patients who had longer hospice stays were 
			admitted to the hospital in the last month of life, compared with 84 
			percent of people with three or fewer days in hospice. 
			 
			"Any use of hospice greatly improves the opportunity to avoid dying 
			in a hospital," said Dr. Laura Hanson of the palliative care program 
			at the University of North Carolina Chapel Hill. 
			"However, patients who enroll in hospice earlier are also avoiding 
			intensive care and hospital stays in the month prior to death," 
			Hanson, who wasn't involved in the study, said by email. "Accepting 
			hospice earlier allows patients to make additional choices about 
			their care." 
			 
			Still, transitioning from dialysis to hospice is a wrenching 
			decision for patients and families, Hanson said. 
			 
			"It takes courage," said Dr. S. Vanita Jassal, director of geriatric 
			and palliative renal care at the University Health Network in 
			Toronto. 
			
			  
			"Patients have often been coached not to miss a session or they 
			could die," Jassal, who wasn't involved in the study, said by email. 
			"We also don't talk about death and how it is inevitable; we often 
			don't empower our patients to tell us when enough is enough." 
			 
			SOURCE: https://bit.ly/2s3lxN5 and https://bit.ly/2J3CosO JAMA 
			Internal Medicine, online April 30, 2018. 
			[© 2018 Thomson Reuters. All rights 
				reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content.  |